Wolf P - Search Results

1

Epidermal Growth Factor Based Targeted Toxin for the Treatment of Bladder Cancer.

Masilamani AP, Fischer A, Schultze-Seemann S, Kuckuck I, Wolf I, Dressler FF, Gratzke C, Wolf P. Masilamani AP, et al. Among authors: wolf i, wolf p. Anticancer Res. 2021 Aug;41(8):3741-3746. doi: 10.21873/anticanres.15165. Anticancer Res. 2021. PMID: 34281832

2

Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.

Elsässer-Beile U, Leiber C, Wetterauer U, Bühler P, Wolf P, Lucht M, Mengs U. Elsässer-Beile U, et al. Among authors: wolf p. Anticancer Res. 2005 Nov-Dec;25(6C):4733-6. Anticancer Res. 2005. PMID: 16334168 Free article. Clinical Trial.

3

Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.

Wolf P, Alt K, Bühler P, Katzenwadel A, Wetterauer U, Tacke M, Elsässer-Beile U. Wolf P, et al. Prostate. 2008 Feb 1;68(2):129-38. doi: 10.1002/pros.20684. Prostate. 2008. PMID: 18044731

4

Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.

Wolf P, Elsässer-Beile U. Wolf P, et al. Int J Med Microbiol. 2009 Mar;299(3):161-76. doi: 10.1016/j.ijmm.2008.08.003. Epub 2008 Oct 23. Int J Med Microbiol. 2009. PMID: 18948059 Review.

5

Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer.

Wolf P, Alt K, Wetterauer D, Bühler P, Gierschner D, Katzenwadel A, Wetterauer U, Elsässer-Beile U. Wolf P, et al. J Immunother. 2010 Apr;33(3):262-71. doi: 10.1097/CJI.0b013e3181c5495c. J Immunother. 2010. PMID: 20445346

6

Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer.

Bühler P, Wetterauer D, Gierschner D, Wetterauer U, Beile UE, Wolf P. Bühler P, et al. Among authors: wolf p. Anticancer Res. 2010 Sep;30(9):3373-9. Anticancer Res. 2010. PMID: 20944111

7

In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer.

Michalska M, Schultze-Seemann S, Bogatyreva L, Hauschke D, Wetterauer U, Wolf P. Michalska M, et al. Among authors: wolf p. Oncotarget. 2016 Apr 19;7(16):22531-42. doi: 10.18632/oncotarget.8001. Oncotarget. 2016. PMID: 26968813 Free PMC article.

8

Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.

Noll T, Schultze-Seemann S, Kuckuck I, Michalska M, Wolf P. Noll T, et al. Among authors: wolf p. Cancer Immunol Immunother. 2018 Mar;67(3):413-422. doi: 10.1007/s00262-017-2097-5. Epub 2017 Nov 29. Cancer Immunol Immunother. 2018. PMID: 29188305 Free PMC article.

9

In Vitro Evaluation of Humanized/De-immunized Anti-PSMA Immunotoxins for the Treatment of Prostate Cancer.

Michalska M, Schultze-Seemann S, Kuckuck I, Wolf P. Michalska M, et al. Among authors: wolf p. Anticancer Res. 2018 Jan;38(1):61-69. doi: 10.21873/anticanres.12192. Anticancer Res. 2018. PMID: 29277757

10

Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells.

Michalska M, Schultze-Seemann S, Kuckuck I, Katzenwadel A, Wolf P. Michalska M, et al. Among authors: wolf p. Anticancer Res. 2018 Mar;38(3):1369-1375. doi: 10.21873/anticanres.12360. Anticancer Res. 2018. PMID: 29491061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,437 results

Search Page

Filters